Form 4: Intuitive Surgical VP Controller Sells Shares After RSU Vesting

Intuitive Surgical's VP Corporate Controller, Fredrik Widman, reported the acquisition of common stock from RSU vesting and subsequent sales for tax withholding and under a 10b5-1 plan.

Summary

• Fredrik Widman, VP Corporate Controller of Intuitive Surgical Inc. (ISRG), reported changes in beneficial ownership.
• On February 10, 2026, 567 shares of common stock were acquired upon the vesting of Restricted Stock Units (RSUs) at a price of $0.0.
• On the same date, 302 shares were disposed of at $492.84 to cover statutory tax withholding requirements.
• On February 11, 2026, an additional 133 shares were sold at $494.96 under a Rule 10b5-1 trading plan.
• Following these transactions, Widman beneficially owns 660 shares of common stock.
• The RSUs vest 25% annually over four years, commencing on each anniversary of February 10, 2023.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical for executive compensation and tax planning, with no direct positive or negative implications for the company's operational performance or future prospects.

Positives

• RSU vesting indicates continued employee retention and the execution of a standard executive compensation structure.
• The sale of shares under a Rule 10b5-1 plan suggests pre-planned, non-discretionary selling, which is generally viewed as a neutral event rather than a reaction to new material information.

Negatives

• Insider selling, even for tax purposes or under a pre-arranged plan, reduces the insider's direct equity stake in the company.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving RSU vesting and subsequent sales for tax or pre-planned purposes, are common in the technology and medical device sectors. These transactions typically reflect executive compensation structures rather than a direct signal about the company's immediate operational performance or strategic direction.

Comparison to Industry Standards

• This type of insider transaction (RSU vesting followed by tax-related sales and 10b5-1 plan sales) is standard practice for executive compensation in publicly traded companies, especially in high-growth sectors like medical technology.
• Companies such as Medtronic (MDT) or Stryker (SYK) often show similar patterns in their Form 4 filings for executives receiving equity compensation.

Stakeholder Impact

• Shareholders: The transactions represent routine executive compensation and tax planning, with negligible impact on overall share count or company fundamentals.
• Employees: Reinforces the company's established equity compensation structure for executives.

Next Steps

• Future RSU vesting events are expected on subsequent anniversaries of February 10, 2023.
• Potential future sales may occur under the Rule 10b5-1 plan until its expiration on May 21, 2026.

Key Dates

Recommendation

The Form 4 filing details routine insider transactions related to RSU vesting and pre-planned sales for tax purposes and under a 10b5-1 plan. These events are common for executive compensation and do not typically signal a change in the company's fundamental outlook or operational performance. Therefore, a 'hold' recommendation is appropriate as this filing does not provide new information to alter an existing investment thesis.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, 10b5-1 Plan, Fredrik Widman, Stock Sale, Corporate Controller